Enveric BiosciencesSTU:SLZ0 30 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 700 Biotechnology companies, Enveric Biosciences ranks worse than 142857% on this metric.
The historical rank and industry rank for Enveric Biosciences's Days Payable or its related term are showing as below:
During the past 13 years, Enveric Biosciences's highest Days Payable was 52.13. The lowest was 48.27. And the median was 50.91.
STU:SLZ0's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.1 * Ranked among companies with meaningful Days Payable only.
Enveric Biosciences's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
Enveric Biosciences Days Payable Related Terms
Enveric Biosciences Days Payable Historical Data
* Premium members only.
The historical data trend for Enveric Biosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:SLZ0 vs APVO, CNSP, ADIL: Days Payable Comparison
For the Biotechnology subindustry, Enveric Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enveric Biosciences Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enveric Biosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Enveric Biosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Enveric Biosciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enveric Biosciences (STU:SLZ0) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Enveric Biosciences and its competitors. Over the past decade, Enveric Biosciences' Days Payable has ranged from 48.27 to 52.13. According to the industry distribution chart, Enveric Biosciences ranks #999999 out of 700 companies in the Biotechnology industry.
Is Enveric Biosciences' Days Payable too high?
Enveric Biosciences' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 48.27 to a high of 52.13. Based on the distribution chart, Enveric Biosciences ranks #999999 out of 700 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Enveric Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' Days Payable compare to APVO and CNSP?
According to the Biotechnology industry distribution chart, Enveric Biosciences ranks #999999 out of 700 companies for Days Payable. This places Enveric Biosciences in the lower half of its industry. The industry median Days Payable is 113.10. Historically, Enveric Biosciences' own Days Payable has ranged from 48.27 to 52.13 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Enveric Biosciences and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enveric Biosciences's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current Days Payable of 0.00. The current Days Payable is 0.00. Enveric Biosciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
30GF Score
Get the complete analysis for STU:SLZ0
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:SLZ0 has been successfully added to your 
